STRO
Sutro Biopharma
15.70$
-0.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 88.3% | 89.5% | 87.9% | 90.7% | 89.8% | 88.7% | 89.4% | 88.3% | 86.9% | 86.8% | 91.3% | 90.3% | |
| 19.0% | 14.7% | 16.2% | 18.6% | 38.6% | 49.1% | 33.0% | 24.4% | 31.4% | 33.4% | 30.4% | 27.9% | |
| 82.3% | 79.8% | 77.6% | 87.1% | 85.9% | 81.8% | 77.5% | 78.2% | 79.9% | 81.4% | 83.7% | 84.5% | |
| 3.9% | 7.7% | 7.8% | 1.4% | 1.5% | 2.2% | 4.2% | 3.0% | 1.9% | 2.3% | 5.2% | 3.0% | |
| 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | |
| 74.0% | 68.2% | 75.7% | 68.9% | 75.4% | 88.5% | 108.0% | 112.2% | 141.6% | 176.2% | 127.6% | 153.1% | |
| 17.0% | 19.9% | 19.7% | 26.6% | 29.1% | 34.1% | 41.4% | 28.3% | 34.3% | 43.2% | 29.3% | 27.2% | |
| 3.1% | 2.2% | 1.7% | 1.4% | 1.6% | 1.9% | 2.4% | 3.1% | 3.8% | 4.5% | 3.1% | 3.4% | |
| 1.3% | 2.0% | 1.9% | 1.2% | 1.4% | 2.7% | 2.5% | 1.6% | 3.4% | 4.4% | 2.3% | 1.7% | |
| 26.0% | 31.8% | 24.3% | 31.1% | 24.6% | 11.5% | -8.0% | -12.2% | -41.6% | -76.2% | -27.6% | -53.1% | |
| -136.8% | -118.8% | -153.1% | -136.1% | -158.1% | -203.2% | -268.4% | -333.3% | -444.1% | -562.6% | -420.0% | -542.5% | |
| 1.4% | 1.3% | 1.5% | 1.7% | 1.8% | 2.1% | 2.6% | 3.2% | 4.0% | 4.9% | 5.4% | 8.5% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.